Proto Labs Inc. (NYSE:PRLB) has received a consensus recommendation of “Hold” from the eight brokerages that are currently covering the firm. Two equities research analysts have rated the stock with a sell recommendation, five have assigned a hold recommendation and one has issued a buy recommendation on the company. The average twelve-month target price among brokerages that have covered the stock in the last year is $68.00.

A number of analysts recently weighed in on the company. Zacks Investment Research downgraded Proto Labs from a “hold” rating to a “sell” rating in a report on Wednesday, November 2nd. Canaccord Genuity downgraded Proto Labs from a “buy” rating to a “hold” rating in a report on Friday, October 28th. Finally, Dougherty & Co downgraded Proto Labs from a “buy” rating to a “sell” rating in a report on Wednesday, August 31st.

Shares of Proto Labs (NYSE:PRLB) opened at 51.75 on Thursday. The firm has a market cap of $1.37 billion, a P/E ratio of 30.09 and a beta of 0.64. The company has a 50 day moving average price of $53.03 and a 200-day moving average price of $57.99. Proto Labs has a 52-week low of $43.10 and a 52-week high of $82.06.

Proto Labs (NYSE:PRLB) last posted its quarterly earnings data on Thursday, October 27th. The company reported $0.45 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.39 by $0.06. The business earned $78.20 million during the quarter, compared to the consensus estimate of $29.97 million. Proto Labs had a return on equity of 13.03% and a net margin of 15.14%. Proto Labs’s quarterly revenue was up 15.3% on a year-over-year basis. During the same period in the prior year, the business posted $0.52 earnings per share. On average, analysts expect that Proto Labs will post $1.79 earnings per share for the current fiscal year.

In related news, insider Arthur R. Baker III acquired 3,000 shares of the business’s stock in a transaction dated Thursday, September 1st. The shares were bought at an average price of $55.00 per share, with a total value of $165,000.00. Following the transaction, the insider now directly owns 7,105 shares of the company’s stock, valued at $390,775. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Insiders own 8.48% of the company’s stock.

Several institutional investors have recently added to or reduced their stakes in PRLB. Brown Capital Management LLC boosted its position in Proto Labs by 0.3% in the second quarter. Brown Capital Management LLC now owns 2,758,736 shares of the company’s stock worth $158,793,000 after buying an additional 6,931 shares during the period. Riverbridge Partners LLC boosted its position in Proto Labs by 8.6% in the third quarter. Riverbridge Partners LLC now owns 1,902,885 shares of the company’s stock worth $114,002,000 after buying an additional 150,739 shares during the period. Vanguard Group Inc. boosted its position in Proto Labs by 2.8% in the second quarter. Vanguard Group Inc. now owns 1,864,255 shares of the company’s stock worth $107,307,000 after buying an additional 51,212 shares during the period. BlackRock Fund Advisors boosted its position in Proto Labs by 9.0% in the third quarter. BlackRock Fund Advisors now owns 1,654,935 shares of the company’s stock worth $99,147,000 after buying an additional 137,230 shares during the period. Finally, TimesSquare Capital Management LLC boosted its position in Proto Labs by 107.2% in the third quarter. TimesSquare Capital Management LLC now owns 1,449,500 shares of the company’s stock worth $86,840,000 after buying an additional 750,000 shares during the period.

About Proto Labs

Proto Labs, Inc is an online and technology-enabled manufacturer of on-demand three-dimensional (3D)-printed, computer numerical control (CNC) machined and injection-molded custom parts for prototyping and short-run production. It utilizes injection molding, CNC machining and 3D printing to manufacture custom parts for its customers.

5 Day Chart for NYSE:PRLB

Receive News & Stock Ratings for Proto Labs Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proto Labs Inc. and related stocks with our FREE daily email newsletter.